These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26876561)

  • 1. Liraglutide Compromises Pancreatic β Cell Function in a Humanized Mouse Model.
    Abdulreda MH; Rodriguez-Diaz R; Caicedo A; Berggren PO
    Cell Metab; 2016 Mar; 23(3):541-6. PubMed ID: 26876561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic mice.
    Tamura K; Minami K; Kudo M; Iemoto K; Takahashi H; Seino S
    PLoS One; 2015; 10(5):e0126003. PubMed ID: 25938469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Study of Liraglutide and Insulin Glargine on Glycemic Control and Pancreatic β-Cell Function in db/db Mice.
    Li Y; Zheng J; Shen Y; Li W; Liu M; Wang J; Zhu S; Wu M
    Med Sci Monit; 2018 May; 24():3293-3300. PubMed ID: 29777582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liraglutide Enhances Autophagy and Promotes Pancreatic β Cell Proliferation to Ameliorate Type 2 Diabetes in High-Fat-Fed and Streptozotocin-Treated Mice.
    Fan M; Jiang H; Zhang Y; Ma Y; Li L; Wu J
    Med Sci Monit; 2018 Apr; 24():2310-2316. PubMed ID: 29664069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide improves pancreatic islet β cell apoptosis in rats with type 2 diabetes mellitus by inhibiting the IKKε/NF-κB pathway.
    Liu YT; He T; Li HQ; Jiang P
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4818-4828. PubMed ID: 34337733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced expression of ERp46 under diabetic conditions in β-cells and the effect of liraglutide.
    Lampropoulou E; Lymperopoulou A; Charonis A
    Metabolism; 2016 Jan; 65(1):7-15. PubMed ID: 26683792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide Activates AMPK Signaling and Partially Restores Normal Circadian Rhythm and Insulin Secretion in Pancreatic Islets in Diabetic Mice.
    Wang K; Sun Y; Lin P; Song J; Zhao R; Li W; Hou X; Wang C; Wang L; Zhu P; Chen L
    Biol Pharm Bull; 2015; 38(8):1142-9. PubMed ID: 26040899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats.
    Trevaskis JL; Sacramento CB; Jouihan H; Ali S; Le Lay J; Oldham S; Bhagroo N; Boland BB; Cann J; Chang Y; O'Day T; Howard V; Reers C; Winzell MS; Smith DM; Feigh M; Barkholt P; Schreiter K; Austen M; Andag U; Thompson S; Jermutus L; Coghlan MP; Grimsby J; Dohrmann C; Rhodes CJ; Rondinone CM; Sharma A
    Diabetes; 2017 Jul; 66(7):2007-2018. PubMed ID: 28408435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repurposed Analog of GLP-1 Ameliorates Hyperglycemia in Type 1 Diabetic Mice Through Pancreatic Cell Reprogramming.
    Villalba A; Rodriguez-Fernandez S; Perna-Barrull D; Ampudia RM; Gomez-Muñoz L; Pujol-Autonell I; Aguilera E; Coma M; Cano-Sarabia M; Vázquez F; Verdaguer J; Vives-Pi M
    Front Endocrinol (Lausanne); 2020; 11():258. PubMed ID: 32477262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide 1 receptor agonist ameliorates the insulin resistance function of islet β cells via the activation of PDX-1/JAK signaling transduction in C57/BL6 mice with high-fat diet-induced diabetes.
    Hao T; Zhang H; Li S; Tian H
    Int J Mol Med; 2017 Apr; 39(4):1029-1036. PubMed ID: 28290604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide protects pancreatic beta cells during an early intervention in Gato-Kakizaki rats.
    Luo X; Pan L; Nie A; Wang Q; Gu Y; Li F; Zhang H; Li W; Li X
    J Diabetes; 2013 Dec; 5(4):421-8. PubMed ID: 23590680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice.
    Merani S; Truong W; Emamaullee JA; Toso C; Knudsen LB; Shapiro AM
    Endocrinology; 2008 Sep; 149(9):4322-8. PubMed ID: 18511515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide prevents β-cell apoptosis via inactivation of NOX2 and its related signaling pathway.
    Ding M; Fang QH; Cui YT; Shen QL; Liu Q; Wang PH; Yu DM; Li CJ
    J Diabetes Complications; 2019 Apr; 33(4):267-277. PubMed ID: 30772113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus.
    Montanya E; Sesti G
    Clin Ther; 2009 Nov; 31(11):2472-88. PubMed ID: 20109994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice.
    Kim SJ; Nian C; Doudet DJ; McIntosh CH
    Diabetes; 2008 May; 57(5):1331-9. PubMed ID: 18299314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice.
    Fosgerau K; Jessen L; Lind Tolborg J; Østerlund T; Schæffer Larsen K; Rolsted K; Brorson M; Jelsing J; Skovlund Ryge Neerup T
    Diabetes Obes Metab; 2013 Jan; 15(1):62-71. PubMed ID: 22862961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.
    Mu J; Woods J; Zhou YP; Roy RS; Li Z; Zycband E; Feng Y; Zhu L; Li C; Howard AD; Moller DE; Thornberry NA; Zhang BB
    Diabetes; 2006 Jun; 55(6):1695-704. PubMed ID: 16731832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BBT improves glucose homeostasis by ameliorating β-cell dysfunction in type 2 diabetic mice.
    Yao XG; Xu X; Wang GH; Lei M; Quan LL; Cheng YH; Wan P; Zhou JP; Chen J; Hu LH; Shen X
    J Endocrinol; 2015 Mar; 224(3):327-41. PubMed ID: 25572265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.